MYLAN-CIMETIDINE DIN 02227460
Health Canada record
| Active ingredient(s) | CIMETIDINE 600 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A02BA01 CIMETIDINE |
| Original market date | 30-May-1997 |
| Current status date | 22-Sep-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mylan Pharmaceuticals ULC — licence 101774, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CIMETIDINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00487872 | CIMETIDINE | AA PHARMA INC | Tablet | CIMETIDINE 300 MG | Marketed |
| 00584215 | CIMETIDINE | AA PHARMA INC | Tablet | CIMETIDINE 200 MG | Marketed |
| 02238161 | TAGAMET PREVENT | MEDTECH PRODUCTS INC | Tablet | CIMETIDINE 200 MG | Approved |
| 00600059 | CIMETIDINE | AA PHARMA INC | Tablet | CIMETIDINE 400 MG | Dormant |
| 00749494 | CIMETIDINE | AA PHARMA INC | Tablet | CIMETIDINE 800 MG | Dormant |
| 00600067 | CIMETIDINE | AA PHARMA INC | Tablet | CIMETIDINE 600 MG | Dormant |
| 00596469 | CIMETIDINE 200 TAB 200MG | PRO DOC LIMITEE | Tablet | CIMETIDINE 200 MG | Cancelled Post Market |
| 00596477 | CIMETIDINE TAB 300MG | PRO DOC LIMITEE | Tablet | CIMETIDINE 300 MG | Cancelled Post Market |
| 00618691 | CIMETIDINE TAB 400MG | PRO DOC LIMITEE | Tablet | CIMETIDINE 400 MG | Cancelled Post Market |
| 00618705 | CIMETIDINE TAB 600MG | PRO DOC LIMITEE | Tablet | CIMETIDINE 600 MG | Cancelled Post Market |
| 02231288 | DOM-CIMETIDINE | DOMINION PHARMACAL | Tablet | CIMETIDINE 400 MG | Cancelled Post Market |
| 02231285 | DOM-CIMETIDINE | DOMINION PHARMACAL | Tablet | CIMETIDINE 200 MG | Cancelled Pre Market |
| 02231287 | DOM-CIMETIDINE | DOMINION PHARMACAL | Tablet | CIMETIDINE 300 MG | Cancelled Post Market |
| 02231290 | DOM-CIMETIDINE | DOMINION PHARMACAL | Tablet | CIMETIDINE 600 MG | Cancelled Post Market |
| 02231291 | DOM-CIMETIDINE | DOMINION PHARMACAL | Tablet | CIMETIDINE 800 MG | Cancelled Pre Market |
| 02237619 | GAVISCON ALL-NIGHT | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | Tablet | CIMETIDINE 100 MG | Cancelled Pre Market |
| 02237010 | GAVISCON PREVENT | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | Tablet | CIMETIDINE 100 MG | Cancelled Post Market |
| 02227436 | GEN-CIMETIDINE TABLETS 200MG | GENPHARM ULC | Tablet | CIMETIDINE 200 MG | Cancelled Post Market |
| 02227452 | MYLAN-CIMETIDINE | MYLAN PHARMACEUTICALS ULC | Tablet | CIMETIDINE 400 MG | Cancelled Post Market |
| 02227444 | MYLAN-CIMETIDINE | MYLAN PHARMACEUTICALS ULC | Tablet | CIMETIDINE 300 MG | Cancelled Post Market |
| 02227479 | MYLAN-CIMETIDINE | MYLAN PHARMACEUTICALS ULC | Tablet | CIMETIDINE 800 MG | Cancelled Post Market |
| 00603686 | NOVO-CIMETINE | TEVA CANADA LIMITED | Tablet | CIMETIDINE 600 MG | Cancelled Post Market |
| 00582409 | NOVO-CIMETINE | TEVA CANADA LIMITED | Tablet | CIMETIDINE 200 MG | Cancelled Post Market |
| 00663727 | NOVO-CIMETINE | TEVA CANADA LIMITED | Tablet | CIMETIDINE 800 MG | Cancelled Post Market |
| 00582417 | NOVO-CIMETINE | TEVA CANADA LIMITED | Tablet | CIMETIDINE 300 MG | Cancelled Post Market |
| 00603678 | NOVO-CIMETINE | TEVA CANADA LIMITED | Tablet | CIMETIDINE 400 MG | Cancelled Post Market |
| 00865796 | NU-CIMET TAB 200MG | NU-PHARM INC | Tablet | CIMETIDINE 200 MG | Cancelled Post Market |
| 00865818 | NU-CIMET TAB 300MG | NU-PHARM INC | Tablet | CIMETIDINE 300 MG | Cancelled Post Market |
| 00865826 | NU-CIMET TAB 400MG | NU-PHARM INC | Tablet | CIMETIDINE 400 MG | Cancelled Post Market |
| 00865834 | NU-CIMET TAB 600MG | NU-PHARM INC | Tablet | CIMETIDINE 600 MG | Cancelled Post Market |
| 00546232 | PEPTOL TAB 200MG | CARTER-HORNER CORP. | Tablet | CIMETIDINE 200 MG | Cancelled Post Market |
| 00546240 | PEPTOL TAB 300MG | CARTER-HORNER CORP. | Tablet | CIMETIDINE 300 MG | Cancelled Post Market |
| 00568449 | PEPTOL TAB 400MG | CARTER-HORNER CORP. | Tablet | CIMETIDINE 400 MG | Cancelled Post Market |
| 00584282 | PEPTOL TAB 600MG | CARTER-HORNER CORP. | Tablet | CIMETIDINE 600 MG | Cancelled Post Market |
| 00618616 | PEPTOL TAB 800MG | CARTER-HORNER CORP. | Tablet | CIMETIDINE 800 MG | Cancelled Post Market |
| 02229721 | PMS-CIMETIDINE | PHARMASCIENCE INC | Tablet | CIMETIDINE 800 MG | Cancelled Post Market |
| 02229720 | PMS-CIMETIDINE | PHARMASCIENCE INC | Tablet | CIMETIDINE 600 MG | Cancelled Post Market |
| 02229719 | PMS-CIMETIDINE | PHARMASCIENCE INC | Tablet | CIMETIDINE 400 MG | Cancelled Post Market |
| 02229718 | PMS-CIMETIDINE | PHARMASCIENCE INC | Tablet | CIMETIDINE 300 MG | Cancelled Post Market |
| 02229717 | PMS-CIMETIDINE | PHARMASCIENCE INC | Tablet | CIMETIDINE 200 MG | Cancelled Post Market |
| 01916815 | TAGAMET 300 | GLAXOSMITHKLINE INC | Tablet | CIMETIDINE 300 MG | Cancelled Post Market |
| 01916785 | TAGAMET 400 | GLAXOSMITHKLINE INC | Tablet | CIMETIDINE 400 MG | Cancelled Post Market |
| 01916777 | TAGAMET 600 | GLAXOSMITHKLINE INC | Tablet | CIMETIDINE 600 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 10579 | 2009-09-11 | New Drug Submission (NDS) | Manufacturer and product name change |
| 4318 | 1996-08-28 | New Drug Submission (NDS) |
International API supply for CIMETIDINE
2 valid EDQM Certificates of Suitability from 2 holders. 2 active FDA Drug Master Files.
Request a quote for MYLAN-CIMETIDINE